Register
Login:
Share:
Email Facebook Twitter




Add Futura Medical to quick picks

Futura Medical Share Price (FUM)



Share Price Information for Futura Medical (FUM)


Share Price: 41.25Bid: 41.00Ask: 41.50Change: 0.00 (0.00%)No Movement on Futura Med.
Spread: 0.50Spread as %: 1.22%Open: 41.25High: 41.25Low: 40.75Yesterday’s Close: 41.25

Futura Medical Plc Ord 0.2P

Futura Medical is listed in the FTSE AIM All-Share
Futura Medical is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
41.25

Share Price SpacerBid
41.00

Share Price SpacerAsk
41.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
221,518

Share Price SpacerOpen
41.25

Share Price SpacerHigh
41.25

Share Price SpacerLow
40.75

Share Price SpacerClose
41.25

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 99.02m £40.85m 7,500

52 Week High 68.75 52 Week High Date 2-MAY-2014
52 Week Low 26.25 52 Week Low Date 21-JAN-2015

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
13 163,744 57,774 -12.313 -3.35 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

27-Mar-15
16:36:53
41.00
30,000
Sell* 
41.00
41.50
12.30k
Trade Type:
Ordinary

27-Mar-15
16:36:45
40.50
30,000
Sell* 
41.00
41.50
12.15k
Trade Type:
Ordinary

27-Mar-15
15:21:21
40.60
3,000
Sell* 
40.50
41.50
1,218
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Futura Medical trades >>

Directors Deals for Futura Medical (FUM)
Trade DateActionNotifierPriceCurrencyAmountHolding
05-Jan-15Buy
Trade Notifier Information for Futura Medical
John M Clarke held the position of Non-Executive Chairman at Futura Medical at the time of this trade.
 John M Clarke
63.25GBX23,43176968
05-Jan-15Buy
Trade Notifier Information for Futura Medical
Jonathan David Freeman held the position of Senior Independent Non-Executive Director at Futura Medical at the time of this trade.
 Jonathan David Freeman
63.25GBX7,46222382
05-Jan-15Buy
Trade Notifier Information for Futura Medical
Lisa Arnold held the position of Independent Non-Executive Director at Futura Medical at the time of this trade.
 Lisa Arnold
63.25GBX9,49926999
View more Futura Medical directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Thu 18:29
alexia93
Updates and posters
41.25
No Opinion

all most interesting. From my own perspective I've decided to put this one in my bottom drawer and take it out for a look at the end of this year. Drug stocks invariably promise much but the downside is usually that it takes a very long time to bring to fulfil that early promise. I have no illusions here but intend to hold long. Gla
Thu 18:19
goldust88
LATEST research report.
41.25
No Opinion

Published today-looks great. http://www.futuramedical.com/content/investors/research.asp
Wed 20:50
goldust88
Info from web results presentation
41.25
No Opinion

Info from presentation http://www.futuramedical.co.uk/archive/2014ar.pdf Weildy-instead of going on a bit you should have listened to results webcast-lots discussed and the future looks much more exciting than the written words.
Wed 12:09
Weildy
Todays updates
41.50
No Opinion

I really cannot see anything to get excited about. More jam tomorrow and missed dates. I have held these for over 5 years now and am getting a bit weary of Mr Barder's smoke and mirrors. Great products, stifled by poor management. The two year shelf life problem is exactly that - a problem and it is increasingly apparent that they will not achieve it. The only bright spot in the report is that they have at last got their asses into gear to progress the TPR products - but I'm not holding my breath. Sorry if this puts a dampener on other investors enthusiasm.
Wed 10:57
handybrownone
Webcast
41.50
No Opinion

Was excellent. On Sales there was a question - so sales in 2.5 months is 40kEuro - on-line only. On-line is only 6-10% of total market. They have 17% of in-line sales already in NL and 10% in BE. It will be going into retail after the update the wholesellers on shelf life info - so 2H 2015. Quick fag packer menas that if they can also create 17% of all retail sales - which I agree is a tall order then annual sales could be in teh order of 2.4mEuro just for NL and BE. The big news really is "lot of interest from big pharma" this is on the topical. The study is enough to apply for approval in some markets. The blow the lights our stuff is teh comparator against ORAL dislofenac. If they show non-infieriorty and plamsa levale of less that 10% or oral it is in effect better and safer than oral in a chronis settting. This is not enough for approval but they would then need a patinet study. If this happens it will blow the lights out. Study results in July will be a major turning point Also erectile gell will launch in UK in 2H 2015 as a "special" in the UK. Study in 140 patients starts today. Shelf life is being worked on - they are confiendet it will improve but they cant gauantee 2 years.
Wed 09:18
Megabux
RNS
41.50
No Opinion

To be honest I'm disappointed. Revenues down significantly on last year and losses up. Shelf life work of CSD 500 was supposed to have been completed at end of last year. No revenue or meaningful sales info for BD. Price however seems to be holding but I've decided to sell up. May come back in later.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Futura Medical (FUM) >>
Please Login or Register to post messages



Futura Medical Plc Ord 0.2P home pageWebsite: Futura Medical Plc Ord 0.2P
Website Description: Welcome to Futura Medical



Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.